Abstract
The shortage of donor livers considered suitable for transplantation has driven the development of novel methods for organ preservation and reconditioning. Machine perfusion techniques can improve the quality of marginal livers, extend the time for which they can be preserved and enable an objective assessment of their quality and viability. These benefits can help avoid the needless wastage of organs based on hypothetical concerns regarding quality. As machine perfusion techniques are gaining traction in clinical practice, attention has now shifted to their potential applications beyond transplantation. As well as providing an update on the current status of machine perfusion in clinical practice, this Perspective discusses how this technology is being used as a tool for therapeutic interventions including defatting of steatotic livers, immunomodulation and gene therapies.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Carrel, A. & Lindbergh, C. A. The culture of whole organs. Science 81, 621–623 (1935).
Starzl, T. E. et al. Orthotopic homotransplantation of the human liver. Ann Surg. 168, 392–415 (1968).
Wahlberg, J. A., Southard, J. H. & Belzer, F. O. Development of a cold storage solution for pancreas preservation. Cryobiology 23, 477–482 (1986).
Adam, R. et al. Effect of extended cold ischaemia with UW solution on graft function after liver transplantation. Lancet 340, 1373–1376 (1992).
Nebrig, M., Neuhaus, P. & Pascher, A. Advances in the management of the explanted donor liver. Nat. Rev. Gastroenterol. Hepatol. 11, 489–496 (2014).
de Vries, R. J. et al. Supercooling extends preservation time of human livers. Nat. Biotechnol. 37, 1131–1136 (2019).
NHS Blood and Transplant. Organ Donation Activity. NHS https://nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/23468/section-3-organ-donation-activity.pdf (2021).
Attia, M., Silva, M. A. & Mirza, D. F. The marginal liver donor–an update. Transpl. Int. 21, 713–724 (2008).
Starzl, T. E. et al. Liver transplantation: an unfinished product. Transpl. Proc. 21, 2197–2200 (1989).
NHS Blood and Transplant. Organ and Tissue Donation and Transplantation Activity Report 2020/21. NHS https://nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/24053/activity-report-2020-2021.pdf (2021).
Wiesner, R. et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124, 91–96 (2003).
Freeman, R. B. Jr. et al. Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula. Liver Transpl. 12 (Suppl. 3), 128–136 (2006).
Dueland, S. et al. Survival following liver transplantation for patients with nonresectable liver-only colorectal metastases. Ann. Surg. 271, 212–218 (2019).
Lunsford, K. E. et al. Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series. Lancet Gastroenterol. Hepatol. 3, 337–348 (2018).
Xu, X. et al. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria. Gut 65, 1035–1041 (2016).
Guarrera, J. V. et al. Hypothermic machine preservation in human liver transplantation: the first clinical series. Am. J. Transpl. 10, 372–381 (2010).
Guarrera, J. V. et al. Hypothermic machine preservation facilitates successful transplantation of “orphan” extended criteria donor livers. Am. J. Transpl. 15, 161–169 (2015).
US National Library of Medicine. ClinicalTrials.gov https://www.clinicaltrials.gov/ct2/show/NCT03484455 (2021).
Schlegel, A. & Dutkowski, P. Role of hypothermic machine perfusion in liver transplantation. Transpl. Int. 28, 677–689 (2015).
Weeder, P. D., van Rijn, R. & Porte, R. J. Machine perfusion in liver transplantation as a tool to prevent non-anastomotic biliary strictures: rationale, current evidence and future directions. J. Hepatol. 63, 265–275 (2015).
Slieker, J. C. et al. Significant contribution of the portal vein to blood flow through the common bile duct. Ann. Surg. 255, 523–527 (2012).
Schlegel, A. et al. Is single portal vein approach sufficient for hypothermic machine perfusion of DCD liver grafts? J. Hepatol. 64, 239–241 (2016).
Dutkowski, P. et al. HOPE for human liver grafts obtained from donors after cardiac death. J. Hepatol. 60, 765–772 (2014).
Schlegel, A. et al. Outcomes of liver transplantations from donation after circulatory death (DCD) treated by hypothermic oxygenated perfusion (HOPE) before implantation. J. Hepatol. 70, 50–57 (2018).
Chouchani, E. T. et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 515, 431–435 (2014).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03124641 (2021).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT01317342 (2021).
van Rijn, R. et al. Dual hypothermic oxygenated machine perfusion in liver transplants donated after circulatory death. Br. J. Surg. 104, 907–917 (2017).
Kamiike, W. et al. Adenine nucleotide metabolism and its relation to organ viability in human liver transplantation. Transplantation 45, 138–143 (1988).
Palombo, J. D. et al. Decreased loss of liver adenosine triphosphate during hypothermic preservation in rats pretreated with glucose: implications for organ donor management. Gastroenterology 95, 1043–1049 (1988).
Cywes, R. et al. Effect of intraportal glucose infusion on hepatic glycogen content and degradation, and outcome of liver transplantation. Ann. Surg. 216, 235–246 (1992). discussion 246-7.
Lanir, A. et al. Hepatic transplantation survival: correlation with adenine nucleotide level in donor liver. Hepatology 8, 471–475 (1988).
van Rijn, R. et al. Hypothermic machine perfusion in liver transplantation–a randomized trial. N. Engl. J. Med. 384, 1391–1401 (2021).
Monbaliu, D. et al. Preserving the morphology and evaluating the quality of liver grafts by hypothermic machine perfusion: a proof-of-concept study using discarded human livers. Liver Transpl. 18, 1495–1507 (2012).
Liu, Q. et al. Assessing warm ischemic injury of pig livers at hypothermic machine perfusion. J. Surg. Res. 186, 379–389 (2014).
Dutkowski, P., Muller, X., Schlegel, A. & Clavien, P. A. Novel real time prediction of liver graft function during hypothermic oxygenated machine perfusion prior to liver transplantation. J. Hepatol. 70, e104–e105 (2019).
Muller, X. et al. Novel real-time prediction of liver graft function during hypothermic oxygenated machine perfusion before liver transplantation. Ann. Surg. 270, 783–790 (2019).
Eshmuminov, D. et al. Perfusion settings and additives in liver normothermic machine perfusion with red blood cells as oxygen carrier. A systematic review of human and porcine perfusion protocols. Transpl. Int. 31, 956–969 (2018).
Bodewes, S. B. et al. Oxygen transport during ex situ machine perfusion of donor livers using red blood cells or artificial oxygen carriers. Int. J. Mol. Sci. 22, 235 (2020).
Ikeda, T. et al. Hemodynamic and biochemical changes during normothermic and hypothermic sanguinous perfusion of the porcine hepatic graft. Transplantation 50, 564–567 (1990).
Schon, M. R. et al. Liver transplantation after organ preservation with normothermic extracorporeal perfusion. Ann. Surg. 233, 114–123 (2001).
Brockmann, J. et al. Normothermic perfusion: a new paradigm for organ preservation. Ann. Surg. 250, 1–6 (2009).
Ravikumar, R. et al. Liver transplantation after ex vivo normothermic machine preservation: a phase 1 (first-in-man) clinical trial. Am. J. Transplant. 16, 1779–1789 (2016).
Nasralla, D. et al. A randomized trial of normothermic preservation in liver transplantation. Nature 557, 50–56 (2018).
Eisenbach, C. et al. An early increase in gamma glutamyltranspeptidase and low aspartate aminotransferase peak values are associated with superior outcomes after orthotopic liver transplantation. Transpl. Proc. 41, 1727–1730 (2009).
Olthoff, K. M. et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl. 16, 943–949 (2010).
Reddy, S. et al. Non-heart-beating donor porcine livers: the adverse effect of cooling. Liver Transpl. 11, 35–38 (2005).
Reddy, S. P. et al. Preservation of porcine non-heart-beating donor livers by sequential cold storage and warm perfusion. Transplantation 77, 1328–1332 (2004).
Perera, T. et al. First human liver transplantation using a marginal allograft resuscitated by normothermic machine perfusion. Liver Transpl. 22, 120–124 (2016).
Mergental, H. et al. Transplantation of declined liver allografts following normothermic ex-situ evaluation. Am. J. Transpl. 16, 3235–3245 (2016).
Ceresa, C. D. L. et al. Transient cold storage prior to normothermic liver perfusion may facilitate adoption of a novel technology. Liver Transpl. 25, 1503–1513 (2019).
Bral, M. et al. A back-to-base experience of human normothermic ex situ liver perfusion: does the chill kill? Liver Transpl. 25, 848–858 (2019).
& Xystrakis, E. et al. Normothemic machine perfusion of liver grafts promotes liver regeneration and inhibits tissue inflammation [abstract]. Am. J. Transpl. 15 (Suppl. 3), 509 (2015).
Selzner, M. et al. Normothermic ex vivo liver perfusion using Steen solution as perfusate for human liver transplantation: first North American results. Liver Transpl. 22, 1501–1508 (2016).
Javanbakht, M. et al. Cost-utility analysis of normothermic liver perfusion with the OrganOx metra compared to static cold storage in the United Kingdom. J. Med. Econ. 23, 1284–1292 (2020).
de Vries, Y. et al. Transplantation of high-risk donor livers after resuscitation and viability assessment using a combined protocol of oxygenated hypothermic, rewarming and normothermic machine perfusion: study protocol for a prospective, single-arm study (DHOPE-COR-NMP trial). BMJ Open 9, e028596 (2019).
He, X. et al. The first case of ischemia-free organ transplantation in humans: a proof of concept. Am. J. Transpl. 18, 737–744 (2018).
Guo, Z. et al. Ischaemia-free liver transplantation in humans: a first-in-human trial. Lancet Reg. Health West Pac. 16, 100260 (2021).
van Leeuwen, O. B., Ubbink, R., de Meijer, V. E. & Porte, R. J. The first case of ischemia-free organ transplantation in humans: a proof of concept. Am. J. Transpl. 18, 2091 (2018).
Imber, C. J. et al. Advantages of normothermic perfusion over cold storage in liver preservation. Transplantation 73, 701–709 (2002).
Mergental, H. et al. Transplantation of discarded livers following viability testing with normothermic machine perfusion. Nat. Commun. 11, 2939 (2020).
van Leeuwen, O. B. et al. Transplantation of high-risk donor livers after ex situ resuscitation and assessment using combined hypo- and normothermic machine perfusion: a prospective clinical trial. Ann. Surg. 270, 906–914 (2019).
Watson, C. J. E. et al. Observations on the ex situ perfusion of livers for transplantation. Am. J. Transpl. 18, 2005–2020 (2018).
Ciria, R. et al. Rescue of discarded grafts for liver transplantation by ex vivo subnormothermic and normothermic oxygenated machine perfusion: first experience in Spain. Transpl. Proc. 51, 20–24 (2019).
Ben-Moshe, S. & Itzkovitz, S. Spatial heterogeneity in the mammalian liver. Nat. Rev. Gastroenterol. Hepatol. 16, 395–410 (2019).
Linares-Cervantes, I. et al. Predictor parameters of liver viability during porcine normothermic ex situ liver perfusion in a model of liver transplantation with marginal grafts. Am. J. Transpl. 19, 2991–3005 (2019).
Matton, A. P. M. et al. Biliary bicarbonate, pH, and glucose are suitable biomarkers of biliary viability during ex situ normothermic machine perfusion of human donor livers. Transplantation 103, 1405–1413 (2019).
Matton, A. P. M. et al. Cell-free microRNAs as early predictors of graft viability during ex vivo normothermic machine perfusion of human donor livers. Clin. Transplant. 34, e13790 (2020).
Butler, A. J. et al. Successful extracorporeal porcine liver perfusion for 72 hr. Transplantation 73, 1212–1218 (2002).
Mergental,H. et al. Transplantation after viability testing of discarded livers with normothermic machine perfusion (NMP): the Vittal (VIability Testing and Transplantation of mArginal Livers) trial 90-day outcomes [abstract 1]. Hepatology 68 (Suppl. 1), 1A (2018).
Eshmuminov, D. et al. An integrated perfusion machine preserves injured human livers for 1 week. Nat. Biotechnol. 38, 189–198 (2020).
Koneru, B. & Dikdan, G. Hepatic steatosis and liver transplantation current clinical and experimental perspectives. Transplantation 73, 325–330 (2002).
Dutkowski, P. et al. The use of fatty liver grafts in modern allocation systems: risk assessment by the balance of risk (BAR) score. Ann. Surg. 256, 861–868 (2012). discussion 868-9.
Nativ, N. I. et al. Liver defatting: an alternative approach to enable steatotic liver transplantation. Am. J. Transpl. 12, 3176–3183 (2012).
Jamieson, R. W. et al. Hepatic steatosis and normothermic perfusion–preliminary experiments in a porcine model. Transplantation 92, 289–295 (2011).
Nagrath, D. et al. Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo. Metab. Eng. 11, 274–283 (2009).
Banan, B., Watson, R., Xu, M., Lin, Y. & Chapman, W. Development of a normothermic extracorporeal liver perfusion system toward improving viability and function of human extended criteria donor livers. Liver Transpl. 22, 979–993 (2016).
Boteon, Y. L. et al. Manipulation of lipid metabolism during normothermic machine perfusion: effect of defatting therapies on donor liver functional recovery. Liver Transpl. 25, 1007–1022 (2019).
Ceresa, C. D. L. et al. Exploring the structural and functional effects of normothermic machine perfusion and de-fatting interventions on human steatotic livers [abstract 3]. Hepatology 68 (Suppl. 1), 2A (2018).
Pruthi, J. et al. Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transpl. 7, 811–815 (2001).
Lau, A. H. et al. Mass cytometry reveals a distinct immunoprofile of operational tolerance in pediatric liver transplantation. Pediatr. Transpl. 20, 1072–1080 (2016).
Schulz-Juergensen, S. et al. Markers of operational immune tolerance after pediatric liver transplantation in patients under immunosuppression. Pediatr. Transpl. 17, 348–354 (2013).
Sakaguchi, S. et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151–1164 (1995).
Todo, S. et al. A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation. Hepatology 64, 632–643 (2016).
Todo, S. & Yamashita, K. Anti-donor regulatory T cell therapy in liver transplantation. Hum. Immunol. 79, 288–293 (2018).
Feng, S. & Sanchez-Fueyo, A. in Pediatric Hepatology and Liver Transplantation (ed. D’Antiga, L.) 625–652 (Springer, 2019).
Jassem, W. et al. Normothermic machine perfusion (NMP) inhibits proinflammatory responses in the liver and promotes regeneration. Hepatology 70, 682–695 (2019).
Goldaracena, N. et al. Inducing epatitis C virus resistance after pig liver transplantation-a proof of concept of liver graft modification using warm ex vivo perfusion. Am. J. Transpl. 17, 970–978 (2017).
Machuca, T. N. et al. Safety and efficacy of ex vivo donor lung adenoviral IL-10 gene therapy in a large animal lung transplant survival model. Hum. Gene Ther. 28, 757–765 (2017).
Baruteau, J. et al. Delivering efficient liver-directed AAV-mediated gene therapy. Gene Ther. 24, 263–264 (2017).
Howick, J. et al. Explanation of the 2011 Oxford Centre for Evidence-Based Medicine (OCEBM) Levels of Evidence (Background Document). Centre for Evidence-Based Medicine https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence (2011).
Bruggenwirth, I. M. A. et al. Extended hypothermic oxygenated machine perfusion enables ex situ preservation of porcine livers for up to 24 hours. JHEP Rep. 2, 100092 (2020).
Author information
Authors and Affiliations
Contributions
All authors researched data for the article, contributed to discussion of content, wrote the article and reviewed and/or edited the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
P.J.F. is co-founder and Chief Medical Officer of OrganOx Ltd, a spin-out company from the University of Oxford that develops normothermic organ perfusion technology. C.D.L.C. has historically received income from OrganOx Ltd. for teaching and training and for carrying out normothermic preservations after normal working hours. The remaining authors declare no competing interests.
Additional information
Peer review information
Nature Reviews Gastroenterology & Hepatology thanks Cristiano Quintini and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ceresa, C.D.L., Nasralla, D., Pollok, JM. et al. Machine perfusion of the liver: applications in transplantation and beyond. Nat Rev Gastroenterol Hepatol 19, 199–209 (2022). https://doi.org/10.1038/s41575-021-00557-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41575-021-00557-8
This article is cited by
-
A machine-learning approach to human ex vivo lung perfusion predicts transplantation outcomes and promotes organ utilization
Nature Communications (2023)
-
SIRT1 regulates hepatocyte programmed cell death via GSDME - IL18 axis in human and mouse liver transplantation
Cell Death & Disease (2023)
-
Liver Transplantation for Nonresectable Colorectal Liver Metastases (CRLM)
Indian Journal of Surgical Oncology (2023)
-
An adaptable research platform for ex vivo normothermic machine perfusion of the liver
International Journal of Computer Assisted Radiology and Surgery (2023)